ARCHIVES

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Funding Opportunities

December 13, 2002

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001